Monopar Therapeutics Files 8-K
Ticker: MNPR · Form: 8-K · Filed: May 13, 2025 · CIK: 1645469
| Field | Detail |
|---|---|
| Company | Monopar Therapeutics (MNPR) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Monopar filed an 8-K on May 13, 2025, for financial reporting.
AI Summary
Monopar Therapeutics Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event.
Why It Matters
This filing signals a routine update from Monopar Therapeutics regarding its financial status and operational results, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting financial results and does not indicate any immediate adverse events or significant changes.
Key Players & Entities
- Monopar Therapeutics Inc. (company) — Registrant
- May 13, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39070 (identifier) — Commission File Number
- 32-0463781 (identifier) — I.R.S. Employer Identification No.
- 1000 Skokie Blvd. , Suite 350 , Wilmette , IL 60091 (address) — Address of principal executive offices
- 847-388-0349 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not include the specific details of these results or conditions.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 13, 2025.
What is the principal executive office address for Monopar Therapeutics Inc.?
The principal executive office address for Monopar Therapeutics Inc. is 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091.
What is the Commission File Number for Monopar Therapeutics Inc.?
The Commission File Number for Monopar Therapeutics Inc. is 001-39070.
What is the I.R.S. Employer Identification No. for Monopar Therapeutics Inc.?
The I.R.S. Employer Identification No. for Monopar Therapeutics Inc. is 32-0463781.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Monopar Therapeutics (MNPR).